Story · Medicine & Biotech · Mind & Brain

Evidence-Based Therapeutic Strategies for Degenerative Neurocognitive Decline in Early Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials

1 outlet · first reported by Cureus on

The early stages of Alzheimer’s disease (AD) consist of mild cognitive impairment (MCI) from AD and mild AD dementia. The early stages offer a crucial opportunity for intervention to reduce cognitive and functional decline. In the last decade, multiple disease-modifying and non-pharmacological… (Cureus)

Coverage, in order

  1. Cureus indie study meta-analysis
    Evidence-Based Therapeutic Strategies for Degenerative Neurocognitive Decline in Early Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials

    The early stages of Alzheimer’s disease (AD) consist of mild cognitive impairment (MCI) from AD and mild AD dementia. The early stages offer a crucial opportunity for intervention to reduce cognitive and functional decline. In the last decade, multiple disease-modifying and non-pharmacological…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.